Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

The Co-Occurrence of 1q21+/1q23+ and t(4;14) Abnormalities with Specific Clone Size Is Predictive of Shorter Response to Transplant in Patients with Multiple Myeloma

Michael P. Ozga, Qiuhong Zhao, Naresh Bumma, Ashley E. Rosko, Abdullah Khan, Srinivas Devarakonda, Elvira Umyarova, Don M. Benson, Jr., Francesca Cottini

Blood (2022) 140 (Supplement 1): 9993–9994.

https://doi.org/10.1182/blood-2022-158693

Published: 2022

Journal Articles

T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant

Alicia Bao, Ruchi Kudalkar, Jose Rodriguez, Qiuhong Zhao, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Abdullah Khan, Ashley E. Rosko, Elvira Umyarova, Don M. Benson, Jr., Francesca Cottini

Blood (2022) 140 (Supplement 1): 7257–7258.

https://doi.org/10.1182/blood-2022-167226

Published: 2022

Journal Articles

Preclinical Development of Hosu-53, a Novel Potent Dihydroorotate Dehydrogenase Inhibitor with Impressive Single Agent Efficacy and Combination Approaches in Hematological Malignancy

Erin Hertlein, Chad Bennett, Ola A Elgamal, Sandip Vibhute, Sharyn Baker, Thomas E Goodwin, Don M. Benson, Jr., Christopher Coss, Jeffrey Patrick, Gerald Hilinski, John C. Byrd

Blood (2022) 140 (Supplement 1): 10695–10696.

https://doi.org/10.1182/blood-2022-167671

Published: 2022

Journal Articles

Final Results from the First-in-Human Phase 1/2 Study of Modakafusp Alfa, an Immune-Targeting Attenuated Cytokine, in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Dan T. Vogl, Shebli Atrash, Sarah A. Holstein, Omar Nadeem, Don M. Benson, Jr., Kaveri Suryanarayan, Yuyin Liu, Sabrina Collins, Xavier Parot, Jonathan L. Kaufman

Blood (2022) 140 (Supplement 1): 1357–1359.

https://doi.org/10.1182/blood-2022-162253

Published: 2022

Journal Articles

Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

Ashley E. Rosko, Kaitlyn Dvorak, Qiuhong Zhao, Electra Paskett, Samantha Jaglowski, James L. Fisher, Jessica Krok-Schoen, Francesca Cottini, Abdullah Khan, Srinivas Devarakonda, Naresh Bumma, Elvira Umyarova, Nidhi Sharma, Don M. Benson, Jr., Jesse Plascak

Blood (2022) 140 (Supplement 1): 5170–5171.

https://doi.org/10.1182/blood-2022-164653

Published: 2022

Journal Articles

Early Versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma

Jordan Nunnelee, Muhammad Salman Faisal, Qiuhong Zhao, Francesca Cottini, Patrick Elder, Ashley E. Rosko, Maria Chaudhry, Abdullah Khan, Srinivas Devarakonda, Naresh Bumma, Don M Benson, Jr., Yvonne A. Efebera, Nidhi Sharma

Blood (2021) 138 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2021-146698

Published: 2021

Journal Articles

CD56 Has a Critical Role in Regulating Multiple Myeloma Cell Growth and Response to Therapies

Francesca Cottini, Jose Rodriguez, Maxwell Birmingham, Tiffany Hughes, Nidhi Sharma, Gerard Lozanski, Bei Liu, Yiping Yang, Emanuele Cocucci, Don M Benson, Jr.

Blood (2021) 138 (Supplement 1): 889.

https://doi.org/10.1182/blood-2021-146370

Published: 2021

Journal Articles

Survival Analysis of Patients with T-Cell Lymphoma or T-Cell Large Granular Leukemia and Concomitant Plasma Cell Dyscrasias

Zachary Braunstein, Miguel Ruiz, Eric McLaughlin, Naresh Bumma, Don M Benson, Jr., Srinivas Devarakonda, Maria Chaudhry, Abdullah Khan, Francesca Cottini, John C. Reneau, Pierluigi Porcu, Anjali Mishra, Ashley E. Rosko, Jonathan E Brammer

Blood (2021) 138 (Supplement 1): 2449.

https://doi.org/10.1182/blood-2021-152556

Published: 2021

Journal Articles

Targeting the Mitotic Checkpoint in Myeloma with OSU-13, a Novel Mps1/Ttk Inhibitor

Larissa Valle Guilhen Longo, Betina McNeil-Laidley, Francesca Cottini, Tiffany Hughes, Gerald Hilinski, Elizabeth Merritt, Don M Benson, Jr.

Blood (2021) 138 (Supplement 1): 2660.

https://doi.org/10.1182/blood-2021-151124

Published: 2021

Journal Articles

Interval Progression Serves As a Predictor of Adverse Outcomes in Patients with Multiple Myeloma

Alicia Bao, Qiuhong Zhao, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Abdullah Khan, Ashley E. Rosko, Don M Benson, Jr., Francesca Cottini

Blood (2021) 138 (Supplement 1): 3940.

https://doi.org/10.1182/blood-2021-147835

Published: 2021

Journal Articles

Effect of Age on Outcomes of Allogeneic Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Blood (2021) 138 (Supplement 1): 3933.

https://doi.org/10.1182/blood-2021-146334

Published: 2021

Journal Articles

Comparison of Bone Marrow Versus Peripheral Blood in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide- a Retrospective Analysis

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-138966

Published: 2020

Journal Articles

Impact of Chronic Graft-Versus-Host Disease on Non-Relapse Mortality

Blood (2020) 136 (Supplement 1): 42.

https://doi.org/10.1182/blood-2020-138755

Published: 2020

Journal Articles

Improvement in Survival of AML and MDS Patients Following Allogeneic Transplant: A Long-Term Institutional Experience

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-139933

Published: 2020

Journal Articles

Trend in Survival in Patients Undergoing Allogeneic Stem Cell Transplantation: An Institutional Experience

Blood (2020) 136 (Supplement 1): 15.

https://doi.org/10.1182/blood-2020-138548

Published: 2020

Journal Articles

Impact of Race and Geographic Location on Outcomes in Allogeneic Transplant

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-140012

Published: 2020

Journal Articles

Comparison of Patient Outcomes with Two Different Formulations of Melphalan As Conditioning Chemotherapy for Autologous Stem Cell Transplantation in Multiple Myeloma

Filiz Yucebay, PharmD, BCPS, BCOP, Ashleigh Keiter, MS, Qiuhong Zhao, MS, Alison Neal, Nita Williams, Nidhi Sharma, PhD, Francesca Cottini, MD, Maria Chaudhry, MD, Ashley Rosko, MD, Don M. Benson, Jr., MD PhD, Yvonne A. Efebera, MD MPH, Naresh Bumma, MD, Abdullah Khan, MBBS, MSc, Srinivas Devarakonda, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-141105

Published: 2020

Journal Articles

Survival Implications of Opioid Use after Blood and Marrow Transplantation

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-134463

Published: 2020

Journal Articles

Improvement in Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience

Jordan Nunnelee, BA, Qiuhong Zhao, MS, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD, Maria Chaudhry, MD, Naresh Bumma, MD, Abdullah Mohammad Khan, MBBS,MSc, Srinivas Devarakonda, MD, Yvonne A. Efebera, MD MPH, Nidhi Sharma, PhD

Blood (2019) 134 (Supplement_1): 4573.

https://doi.org/10.1182/blood-2019-121845

Published: 2019

Journal Articles

Daratumumab-Mediated Lymphocyte Kinetics Predict Adverse Events and Survival Outcomes in Patients with Multiple Myeloma

Francesca Cottini, MD, Nita Williams, Naresh Bumma, MD, Abdullah Mohammad Khan, MBBS, MSc, Maria Chaudhry, MD, Srinivas Devarakonda, MD, Yvonne A. Efebera, MD MPH, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD

Blood (2019) 134 (Supplement_1): 5501.

https://doi.org/10.1182/blood-2019-129128

Published: 2019

NARROW

The Co-Occurrence of 1q21+/1q23+ and t(4;14) Abnormalities with Specific Clone Size Is Predictive of Shorter Response to Transplant in Patients with Multiple Myeloma

T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant

Preclinical Development of Hosu-53, a Novel Potent Dihydroorotate Dehydrogenase Inhibitor with Impressive Single Agent Efficacy and Combination Approaches in Hematological Malignancy

Final Results from the First-in-Human Phase 1/2 Study of Modakafusp Alfa, an Immune-Targeting Attenuated Cytokine, in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

Early Versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma

CD56 Has a Critical Role in Regulating Multiple Myeloma Cell Growth and Response to Therapies

Survival Analysis of Patients with T-Cell Lymphoma or T-Cell Large Granular Leukemia and Concomitant Plasma Cell Dyscrasias

Targeting the Mitotic Checkpoint in Myeloma with OSU-13, a Novel Mps1/Ttk Inhibitor

Interval Progression Serves As a Predictor of Adverse Outcomes in Patients with Multiple Myeloma

Effect of Age on Outcomes of Allogeneic Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Comparison of Bone Marrow Versus Peripheral Blood in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide- a Retrospective Analysis

Impact of Chronic Graft-Versus-Host Disease on Non-Relapse Mortality

Improvement in Survival of AML and MDS Patients Following Allogeneic Transplant: A Long-Term Institutional Experience

Trend in Survival in Patients Undergoing Allogeneic Stem Cell Transplantation: An Institutional Experience

Impact of Race and Geographic Location on Outcomes in Allogeneic Transplant

Comparison of Patient Outcomes with Two Different Formulations of Melphalan As Conditioning Chemotherapy for Autologous Stem Cell Transplantation in Multiple Myeloma

Survival Implications of Opioid Use after Blood and Marrow Transplantation

Improvement in Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience

Daratumumab-Mediated Lymphocyte Kinetics Predict Adverse Events and Survival Outcomes in Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only